|
|
Kewaunee Scientific Corporation (NASDAQ: KEQU) |
|
|
|
Kewaunee Scientific's Operating Profit Margin, Return on Sales by quarter
Trends, Rankings, Statistics
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Profit Margin, Return on Sales ▼
|
Operating Profit Margin, Return on Sales ▼
|
KEQU Operating Profit Margin, Return on Sales |
(Jan 31 2025) Q3 |
(Oct 31 2024) Q2 |
(Jul 31 2024) Q1 |
(Apr 30 2024) Q4 |
(Jan 31 2024) Q3 |
Y / Y Revenue Change |
44.21 % |
-5.09 % |
-2.92 % |
8.62 % |
-24.32 % |
Seq. Revenue Change |
41.38 % |
-1.13 % |
-19.02 % |
27.4 % |
-6.95 % |
Revenue In Millions |
$66.38 |
$46.95 |
$47.49 |
$58.64 |
$46.03 |
Operating Profit Margin, Return on Sales |
3.39 % |
9.44 % |
5.42 % |
9.48 % |
8.27 % |
Operating Profit Margin, Return on Sales Total
Ranking |
# 2330 |
# 1731 |
# 2124 |
# 1676 |
# 1951 |
Operating Income In Millions |
$2.25 |
$4.43 |
$2.58 |
$5.56 |
$3.81 |
Y / Y Operating Income Change |
-40.88 % |
-13.21 % |
-32.38 % |
105.78 % |
65.19 % |
Seq. Operating Income Change |
-49.26 % |
72.19 % |
-53.67 % |
46.03 % |
-25.5 % |
Commenting Third Quarter 2024 Operating Profit Margin, Return on Sales |
Company's Operating Profit Margin, Return on Sales sequentially deteriorated to 3.39 % due to increase in Operating Costs and despite Revenue increase of 41.38 % to $66 millions. Company's Operating Profit Margin, Return on Sales in III. Quarter, was lower than company average.
Observing third quarter 2024 results within Laboratory Analytical Instruments industry 8 other companies have achieved higher Operating Profit Margin, Return on Sales. While Operating Profit Margin, Return on Sales overall ranking has deteriorated relative to the three months before, from 1731 to 2330.
Explain Operating Margin
|
KEQU's Operating Profit Margin, Return on Sales third quarter 2024 Company Ranking |
Within: |
No. |
Laboratory Analytical Instruments Industry |
# 9 |
Healthcare Sector |
# 199 |
Overall |
# 2329 |
Operating Profit Margin, Return on Sales Statistics |
High |
Average |
Low |
10.33 % |
5.12 % |
1.38 % |
(Oct 31 2023) |
|
(Oct 31 2022) |
Companies with similar Operating Profit Margin, Return on Sales in the quarter ending Jan 31 2025, within Laboratory Analytical Instruments Industry | Operating Profit Margin, Return on Sales | Jan 31 2025 MRQ Operating Income | Jan 31 2025 MRQ Revenue | Bio rad Laboratories Inc | 8.72 % | $ 58.330 Millions | $ 668.912 Millions | Cytek Biosciences Inc | 5.09 % | $ 2.986 Millions | $ 58.652 Millions | Kewaunee Scientific Corporation | 3.39 % | $ 2.250 Millions | $ 66.379 Millions | 10x Genomics Inc | 1.96 % | $ 3.219 Millions | $ 164.646 Millions |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com